PCMC
MRNA icon

Planning Capital Management Corporation’s Moderna MRNA Stock Holding History

Planning Capital Management Corporation’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$67 Hold
1
– – ﹤0.01% 729
2024
Q2 		$119 Buy
+1
New +$127 ﹤0.01% 661

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Planning Capital Management Corporation's MRNA Position: Q3 2024 in Review

Planning Capital Management Corporation held its Moderna (MRNA) position steady in Q3 2024 at 1 share worth $67. The position accounts for ﹤0.01% of the portfolio, ranked #729.

Planning Capital Management Corporation first reported a position in MRNA in Q2 2024 and has held it in 2 quarters since. The position peaked at $119 in Q2 2024. 789 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Planning Capital Management Corporation held 1 share of Moderna worth $67 as of Q3 2024.
  • Planning Capital Management Corporation left its Moderna share count unchanged in Q3 2024.
  • Moderna made up ﹤0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #729 holding.
  • Planning Capital Management Corporation first reported a position in Moderna in Q2 2024 and has held it in 2 quarters since.
  • Planning Capital Management Corporation's Moderna position peaked at $119 in Q2 2024.
  • 789 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.